Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Mattsson

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Molecular Biology|October 26, 1999
Roles for glycosylation of cell surface receptors involved in cellular immune recognitionP M Rudd, M R Wormald, R L Stanfield, et al.
Molecular Psychiatry|February 20, 2013
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4U Andreasson, R Lautner, J M Schott, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2021
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development frameworkA Leuzy, N J Ashton, N Mattsson-Carlgren, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2021
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkersN J Ashton, A Leuzy, T K Karikari, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2009
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosisN Mattsson, M Axelsson, S Haghighi, et al.
Neurology|February 4, 2012
Age and diagnostic performance of Alzheimer disease CSF biomarkersN Mattsson, E Rosén, O Hansson, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Molecular Biology|October 26, 1999
Roles for glycosylation of cell surface receptors involved in cellular immune recognitionP M Rudd, M R Wormald, R L Stanfield, et al.
Molecular Psychiatry|February 20, 2013
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4U Andreasson, R Lautner, J M Schott, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2021
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development frameworkA Leuzy, N J Ashton, N Mattsson-Carlgren, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2021
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkersN J Ashton, A Leuzy, T K Karikari, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2009
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosisN Mattsson, M Axelsson, S Haghighi, et al.
Neurology|February 4, 2012
Age and diagnostic performance of Alzheimer disease CSF biomarkersN Mattsson, E Rosén, O Hansson, et al.
Pageof 2